Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2005-04-05
2005-04-05
Harris, Alana M. (Department: 1642)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S325000, C435S343200, C435S363000, C514S001000, C514S002600, C514S008100, C514S013800, C514S014800, C514S015800, C514S017400, C514S018700, C514S019300, C514S023000, C514S054000, C530S300000
Reexamination Certificate
active
06875609
ABSTRACT:
The disclosed nucleic acid primer sets, used in combination with quantitative amplification (PCR) of tissue cDNA, can indicate the presence of specific proteases in a tissue sample. Specifically, the present invention relates to expression of hepsin protease. The detected proteases are themselves specifically over-expressed in certain cancers, and the presence of their genetic precursors may serve for early detection of associated ovarian and other malignancies, and for the design of interactive therapies for cancer treatment.
REFERENCES:
patent: 6232456 (2001-05-01), Cohen et al.
Paglia et al. Murine Dendritic Cells Loaded In Vitro with Soluble Protein Prime Cytotoxic T Lymphocytes against Tumor Antigen In Vivo. J. Exp. Med 183: 317-322, Jan. 1996.*
Gura. Systems for Identifying New Drugs are Often Faulty, Science 278:1041 and 1042, Nov. 7, 1997.*
Jain. Barriers to Drug Delivery in Solid Tumors. Scientific American 271(1): 58-65, Jul. 1994.*
Sequence from U.S. patent 6,232,456 issued May 2001.
Cannon Martin J.
O'Brien Timothy J.
Santin Alessandro
Adler Benjamin Aaron
Harris Alana M.
The University of Arkansas For Medical Sciences
LandOfFree
Methods for the early diagnosis of ovarian cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the early diagnosis of ovarian cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the early diagnosis of ovarian cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3397010